NetworkNewsBreaks Archive - Page 2085 of 2179

MondayMay 22, 2017 12:50 pm

NetworkNewsBreaks – Lantronix, Inc. (NASDAQ: LTRX) Commences Beta Release of MACH10™ IoT Application Development and Deployment Platform

Lantronix (NASDAQ: LTRX) shares are nudging higher after the company announced the availability of the beta release of its MACH10™. The multi-dimensional IoT application development and deployment platform simplifies the process for OEMs to deliver web-scale IoT applications. MACH10 allows OEMs to considerably reduce the amount of time spent in developing IoT applications through extensible ready-to-use management applications that can be deployed instantly. "This beta release marks another important milestone as we move towards general availability of MACH10 later this calendar year and accomplishing Lantronix's mission to deliver easy-to-deploy solutions that enable companies to leverage the benefits of the Internet…

MondayMay 22, 2017 11:34 am

NetworkNewsBreaks – Biocept, Inc. (NASDAQ: BIOC) Move Higher on Heavy Volume Following Patent News

Shares of Biocept (NASDAQ: BIOC) are up more than 6%, continuing a pre-bell rally on news that the commercial provider of liquid biopsy tests designed to ultimately improve the outcomes of cancer patients was awarded U.S. Patent No. 9671407, entitled DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS. The patent – the company’s 20th issued patent in the U.S. and key international territories - covers the broad use of antibodies for the capture of any target of interest on any solid surface from any sample type. Targets of interest include, but are not limited to, circulating tumor cells (CTCs), sub-cellular…

MondayMay 22, 2017 8:49 am

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Positioned for Growth with Utilization of Unique Business Models, Revenue Streams

Player’s Network, Inc. (OTCQB: PNTV), a fully reporting diversified holdings company, operates in the medical marijuana and media industries and is focused on the chief objective of creating shareholder value by locating and unlocking opportunities in niche emerging markets. The company has three prominent subsidiaries operating under profitable business models: Next Gen TV, WeedTV.com and Green Leaf Farms. “Player’s Network also owns 86% of Green Leaf Farms Holdings, LLC, better known as Green Leaf. To generate revenue, the company has identified the “best breed” operators to ensure the highest quality of medical marijuana and edibles. These are then legally sold…

FridayMay 19, 2017 12:45 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 19, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DXLG 7.50% – News: Posts Q1 2017 results REFR 7.00% – News: Enters commercial agreement with PPG Aerospace LXRP 6.45% – News: Raises $1M from warrant exercise CDNA 6.32% – News: Posting preliminary Q1 2017 financial results, hosting conference call on May 22 AVEO 5.88% – News: Completes oral explanation to the CHMP for tivozanib marketing authorization application review JMU 3.29% – News: Releasing Q4, FY 2016 results and hosting conference call on May…

FridayMay 19, 2017 12:42 pm

NetworkNewsBreaks – Ethema Health Corp.’s (GRST) Seastone Facility Offers Range of Specialized Addiction Treatment Programs

Seastone of Delray – Drug Rehabilitation and Alcohol Treatment Center, owned and operated by Ethema Health Corporation (OTCQB: GRST) (formerly GreeneStone Healthcare Corporation), may be one of many substance abuse recovery and treatment facilities in Florida, but it stands out from the crowd due to the highly efficient individualized treatment options offered. Seastone is distinguished by a broad range of treatment programs – offered at varying intensities depending on the needs of the individual client - and careful attention paid to the individual client and family, ensuring a highly detailed assessment is conducted prior to the creation of a specialized…

FridayMay 19, 2017 11:03 am

NetworkNewsBreaks – Bollente Companies, Inc. (BOLC) Stands Out as ‘One to Watch’

Bollente Companies (OTC: BOLC) is developing a diverse portfolio of companies, specifically targeting disruptive technologies with the potential to positively impact the environment and emerging economies. The company’s current focus is on high-efficiency electric tankless water heaters manufactured and sold under Bollente’s “trutankless” division, including a line of economy tankless water heaters sold under the Vero name. “By maintaining 99 percent efficiency, Bollente’s trutankless heaters use less energy than tank heaters, while providing the convenience of always-hot water. The system only uses power when there is demand, producing water to exact temperature, within one degree, even with sudden changes to…

FridayMay 19, 2017 11:01 am

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Poised to Capitalize on China’s Changing Consumer Market

China’s economy is in the midst of a structural transition, and to capture the vast new opportunities within this changing consumer market, companies need to develop strategies that accommodate rapid shifts in the nature of consumption. “Despite a slowing economy, China will remain one of the fastest growing consumer markets in the world for the foreseeable future. Moxian, Inc. (NASDAQ: MOXC) is serving those businesses that are feeding the demands of the new Chinese consumer. Moxian provides small- and medium-sized businesses cutting edge turnkey solutions to attract and maintain customers. The company’s strategy is to drive consumer traffic from online…

ThursdayMay 18, 2017 1:44 pm

NetworkNewsBreaks – Aegis Capital Covers Inovio Pharmaceuticals, Inc. (NASDAQ: INO) with “Buy” Rating, $11 PT

Aegis Capital has issued a ‘Buy’ rating and price target of $11 on shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO). The analyst noted that Inovio is awaiting response from the FDA regarding the clinical hold on VGX-3100 phase 3, which is expected to be resolved this month. The company plans to initiate its phase 3 trial with VGX-3100 for HPV-related cervical dysplasia by the second half of 2017. The trial is expected to last approximately two years, with NDA submission in 2020 and product launch in 2021. For more information, visit www.inovio.com About Inovio Pharmaceuticals, Inc. Inovio is taking immunotherapy…

ThursdayMay 18, 2017 1:43 pm

NetworkNewsBreaks – Aegis Capital Reiterates “Buy” Rating on Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Aegis Capital has reiterated a ‘Buy’ rating and price target of $25 on shares of Concert Pharmaceuticals, Inc. (NASDAQ: CNCE). The company recently said it has received notice from the FDA that its CTP-543 phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA is requesting a review of non-clinical toxicology studies to evaluate the planned one-year dosing. Concert said it intends to submit a response shortly, which the FDA will review within 30 days. The analyst noted the hold and said he believes the issue will be easily resolved without a long delay in…

ThursdayMay 18, 2017 12:09 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ARQL 34.12% – News: Presenting at EHA Congress on June 23 in Madrid, Spain TNTY 21.88% – News: Forms joint-venture subsidiary MRMD 10.01% – News: Reports Q1 2017 revenue OPXS 4.17% – News: Secures $2.16M supplier agreement SIRI 4.02% – News: Launches new talk show with actress Anne Heche QUMU 3.47% – News: Unveils Qx video platform VSTM 3.12% – News: Presenting at EHA Congress on June 25 CASI 3.09% – News: Presenting at…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks